arrow_back Back to App

Drug Price Negotiation Changes: More Time for Innovation.

This act changes drug price negotiation rules, giving pharmaceutical companies more time to recoup research and development costs. This means new drugs, especially innovative ones, will be on the market longer without price negotiations, potentially affecting their availability and cost for patients in the future.
Key points
Extends the period before the government can negotiate drug prices from 7 to 11 years after approval for certain drugs.
This change applies to drugs introduced from 2028 onwards, aiming to support the development of new therapies.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_S_832
Sponsor: Sen. Tillis, Thomas [R-NC]
Process start date: 2025-03-04